Medication info
Vivante Tablet 20 mg (Bazedoxifene Acetate)

Vivante Tablet 20 mg (Bazedoxifene Acetate)

Prescription medicationTabletOral
Ingredient · strength
Bazedoxifene Acetate›22.6mg / 1 tablet
Manufacturer / importer
Pfizer Pharmaceuticals Korea Limited
Appearance
White to grayish-white capsule-shaped film-coated tablet
Packaging
28 tablets (28/blister x 1)
Approval status
Active

MFDS item code 201110095 · Approved 2011.11.16 · Insurance code 648902000

Summary

Main use
Treatment and prevention of osteoporosis in postmenopausal women
Who takes it
Adults
Adult dose
Take 1 tablet once daily (equivalent to 20mg of bazedoxifene), with or without food. If the patient's intake of calcium and vitamin D from food is insufficient, supplements should be taken. Patients with renal impairment: This drug has not been adequately evaluated in patients with severe renal impairment and should be administered with caution. No dose adjustment is necessary in patients with mild or moderate renal impairment. Patients with hepatic impairment: This drug is not recommended for use in patients with hepatic impairment because its safety and efficacy have not been established.

Ingredients

Importer
Pfizer Pharmaceuticals Korea Limited

Efficacy & effects

Treatment and prevention of osteoporosis in postmenopausal women

  • Osteoporosis
  • spinal fractures
View approved original text

This medication is used for the treatment and prevention of osteoporosis in postmenopausal women. It is particularly effective in reducing the occurrence of spinal fractures, while its effect on non-vertebral fractures is not yet certain. Thus, it helps reduce the risk of spinal fractures due to osteoporosis.

How to take

Adult dose

Take 1 tablet once daily (equivalent to 20mg of bazedoxifene), with or without food. If the patient's intake of calcium and vitamin D from food is insufficient, supplements should be taken. Patients with renal impairment: This drug has not been adequately evaluated in patients with severe renal impairment and should be administered with caution. No dose adjustment is necessary in patients with mild or moderate renal impairment. Patients with hepatic impairment: This drug is not recommended for use in patients with hepatic impairment because its safety and efficacy have not been established.

Precautions

This medication can increase the risk of blood clots in the bloodstream. The risk of venous thromboembolism is highest during the first year of treatment, so caution is necessary. This medication is intended for use only in postmenopausal women and is not recommended for premenopausal women. If uterine bleeding occurs while taking this medication, a healthcare professional must be consulted for diagnosis. Its safety has not been established in patients with breast cancer, and it should not be used for prevention or treatment purposes. Individuals with allergies to this medication or its ingredients should avoid taking it, and those with a history of thrombosis should not use it. Women who are pregnant or may become pregnant and nursing mothers should not take this medication. Individuals with unexplained uterine bleeding or symptoms of endometrial cancer should also not use this medication. This medication contains lactose, so individuals with lactose intolerance should exercise caution. Patients with severe hypertriglyceridemia or severe renal or hepatic impairment should use this medication with caution. While taking this medication, side effects such as facial flushing, leg cramps, dry mouth, skin rash, drowsiness, etc. may occur, requiring attention. If symptoms affecting vision arise, it is advisable to consult a doctor immediately, and it is recommended to avoid driving or operating machinery until the symptoms resolve. This medication has a low potential for drug interactions, but if used in combination with certain drugs, the effect may change, so it is essential to consult a doctor or pharmacist. In case of overdose, there are no specific antidotes, so appropriate treatment should be provided according to the symptoms. Keep out of reach of children and store in the original container sealed to maintain the quality of the medication.

Side effects

  • hypersensitivity
  • drowsiness
  • retinal vein thrombosis
  • facial flushing
  • deep vein thrombosis
  • superficial venous thrombosis
  • pulmonary embolism
  • dry mouth
  • urticaria
  • rash
Show 69 more
  • itching
  • muscle cramps
  • peripheral edema
  • increased serum triglycerides
  • elevated alanine aminotransferase
  • elevated aspartate aminotransferase
  • decreased vision
  • blurred vision
  • photophobia
  • visual field defect
  • visual impairment
  • dry eye syndrome
  • eyelid swelling
  • eyelid spasm
  • eye pain
  • eye swelling
  • vomiting
  • gastritis
  • colonic polyps
  • belching
  • death
  • fever
  • generalized edema
  • fatigue
  • allergic reaction
  • chest discomfort
  • leg pain
  • edema
  • facial edema
  • altered temperature sensation
  • lethargy
  • asthenia
  • inadequate effect
  • dermatitis
  • localized skin reaction
  • increased sweating
  • eczema
  • hair loss
  • back pain
  • joint pain
  • muscle weakness
  • shoulder rotator cuff syndrome
  • headache
  • dizziness
  • pharyngitis
  • pyelonephritis
  • palpitations
  • bronchial disease
  • cough
  • asthma
  • difficulty breathing
  • laryngitis
  • increased alkaline phosphatase
  • liver cyst
  • hepatocyte damage
  • bile duct stones
  • weight gain
  • hyperlipidemia
  • central obesity
  • urinary difficulty
  • abnormal urination
  • renal cyst
  • urinary incontinence
  • vaginal bleeding
  • breast congestion
  • insomnia
  • leukocytosis
  • laceration
  • contusion

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to prevent air and moisture from entering and kept in a cool place below 25 degrees Celsius. Storing it this way will help maintain the medication's effectiveness for a longer period.

Appearance and packaging

Appearance

White to grayish-white capsule-shaped film-coated tablet

Package unit

28 tablets (28/blister x 1)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.